Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
The Lancet: Mass imprisonment of drug users driving global epidemics of HIV, hepatitis, and tuberculosis

The War on Drugs, mass incarceration of drug users, and the failure to provide proven harm reduction and treatment strategies has led to high levels of HIV, tuberculosis, and hepatitis B and C infection among prisoners--far higher than in the general population. With an estimated 30 million people passing in and out of prisons every year, prisoners will be key to controlling HIV and tuberculosis epidemics worldwide, according to a major six-part Series on HIV and related infections in prisoners, published in The Lancet and being presented at the International AIDS Conference in Durban, South Africa.

Published
17 July 2016
From
EurekAlert
“Towards Ending the Neglect?” DNDi Releases Update on its Paediatric HIV Programme

The Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treat­ment regimen for infants and young chil­dren.

Published
17 July 2016
From
DNDi
TB2016 highlights efforts to strengthen the global fight against tuberculosis, the leading killer of people with HIV

Urgency in efforts to address the devastating global impact of tuberculosis (TB), and opportunities to make major inroads against the infectious disease, are being featured at TB2016, a two-day conference dedicated exclusively to TB, immediately preceding AIDS 2016 in Durban, South Africa.

Published
16 July 2016
From
AIDS 2016
Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen

These FAQs address key points regarding the implementation of the WHO treatment guidelines for drug-resistant tuberculosis, 2016 update, in TB and TB/HIV programmes.

Published
15 June 2016
From
World Health Organization
UNITAID launches global initiative to prevent tuberculosis

UNITAID is calling for innovative proposals to make new, shorter preventive treatment regimens more easily available to those who could benefit most. The proposals that show most promise will be recommended for funding.

Published
25 May 2016
From
UNITAID
New TB skin test safe, easy to use

A new skin test for latent M. tuberculosis, was safe and easy to use, and addresses the problem of false positive skin test results in patients who have received the BCG vaccine, according to data presented at the American Thoracic Society 2016 International Conference.

Published
24 May 2016
From
Healio
The Worst Superbug? Tuberculosis

The ground-breaking publication of Lord Jim O'Neill's global Review on Antimicrobial Resistance (AMR) is the wake-up call the world desperately needs. Have no doubts: the 'superbugs' that develop antimicrobial resistance are a threat of immense proportions and have a potential impact of 10 million deaths a year by 2050 as antibiotic efficacy dwindles.

Published
20 May 2016
From
Huffington Post UK
Leave no one behind: Stop TB Partnership launches seven key population briefs

The Stop TB Partnership today launched a series of briefs on TB key populations recognizing that reaching everyone with services, diagnostics, treatment and care is essential to ending the TB epidemic.

Published
17 May 2016
From
Stop TB Partnership
Rapid diagnostic test and shorter, cheaper treatment signal new hope for multidrug-resistant tuberculosis patients

New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.

Published
12 May 2016
From
World Health Organization
If we want to end HIV, TB, and malaria, we need to do more to reduce human rights barriers

A recent report from UNAIDS said that by 2020, countries should devote 8% of its HIV resources to reducing human rights barriers to accessing services. Currently, less than 1% of Global Fund grant funds is spent on programs to reduce human rights barriers. We have to do more and we have to do it better, says Ralf Jürgens. In this commentary, Ralf describes an intensive effort that the Global Fund is implementing in 15-20 countries, as well as other initiatives the Fund has planned.

Published
11 May 2016
From
Global Fund Observer

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.